It is every APRNs fiscal responsibility to understand the revenue stream within a practice whether employed or owner of a practice. APRN education focuses on the clinical aspects of training and little on the business side of generating revenue for a practice by maximizing correct coding and documentation for APRN services. Coding and billing can make an NP visible to payers which can enhance value. Learn how to reduce the likelihood of denials which affect the bottom line. Learn the tools to enhance documentation and reduce burden to have more time with patients and better work life balance. APRNs that can accurately document and code their services bring value to a practice and add to the evidence base for the quality and cost-effectiveness of APRN care.

I plan on discussing the basics for starting a NP based practice. I plan on going through details such as identifying marketing strategies for growing your practice, importance of negotiating insurance contracts, when to hire help for your practice, short discussion on ACOs, and how to properly bill an annual wellness visit. The whole presentation will be given over lecture and PowerPoint. By the end of the presentation, the attendees should have a better understanding and knowledge of how to start their own practice or add to their current practice.

This session examines the foundational elements of business plan construction for nurse practitioners pursuing independent practice. Drawing from entrepreneurial frameworks and healthcare business models, participants will explore the essential components of a comprehensive practice plan, including organizational structure determination, market analysis methodology, operational workflow design, and financial projection development. Special attention will be given to the decision-making process surrounding value-based care program participation and the strategic allocation of consulting resources during the practice establishment phase. The session presents evidence-based approaches to practice viability assessment and sustainability planning within varying regulatory environments. Through structured analysis of practice models and their financial implications, participants will develop competency in translating clinical expertise into pragmatic business frameworks. This module serves as a critical component within the broader curriculum addressing independent practice development for advanced practice nurses.

Opening a specialty practice can be a challenge to overcome or embraced as a wonderful opportunity. This session will discuss how to startup and sustain a specialty practice. It begins with a natural disaster and leads to opening day, attend and be inspired consider nurse practitioner entrepreneurship!

Practice ownership and being a nurse practitioner entrepreneur is not for the faint of heart, but more and more NPs are choosing to go into business for themselves rather than join a large healthcare system or physician-owned practice. This presentation will discuss the work involved in starting a practice including barriers encountered, goals achieved, and lessons learned by a long-time NP practice owner.

A high level overview of contracts including the elements of enforceability, core components of a contract, areas of special focus, and intricacies involved in special contracts. Healthcare related examples will be reviewed.

Exploring mental health disparities within Florida and discussing rural home-based psychiatric care.

The physiologically difficult airway is a derangement of physiology that places a patient at higher risk of peri-intubation cardiovascular collapse. This presentation will review the common types of physiologically dangerous airways and how to approach them safely, as well as some tips on induction agents, ventilator management, and rescue therapies. Our objectives are to review the relevant literature, classify types of difficult airways, discuss physiologic derangements associated with intubation, and then apply what we’ve learned over a few case studies.

This session will provide an evidence-based overview of the management of acute respiratory failure in adult patients. We will begin with a review of the two primary types of respiratory failure—hypoxic and hypercapnic—including common etiologies, underlying pathophysiology, and clinical presentations. The focus will then shift to high-flow nasal cannula (HFNC) systems such as Optiflow and Vapotherm, as well as noninvasive mechanical ventilation (BiPAP/CPAP). I will cover the physiology, mechanisms of action, and clinical indications for each modality, followed by best practices for initiating, managing, and weaning support. Recent evidence and guideline updates published in CHEST on HFNC and noninvasive ventilation will be highlighted. The session will also address how to recognize clinical deterioration and when escalation of care is warranted. Designed for acute care nurse practitioners, this presentation will offer practical strategies and clinical pearls to support bedside decision-making and optimize respiratory support for critically ill patients.

Understanding how to optimize cardiac output is essential for managing critically ill patients; however, many providers struggle to translate the equation CO = SV × HR into practical bedside action. This session breaks down cardiac output into its core components—preload, afterload, contractility, and heart rate—and examines the pharmacologic tools used in the ICU to influence each variable. Attendees will review commonly used ICU medications, including vasopressors, inotropes, vasodilators, and fluid strategies, along with their impact on cardiac performance. Whether adjusting volume status, titrating vasopressors, or managing tachyarrhythmias, this talk will provide the physiologic context and clinical reasoning for each intervention. Intended for nurse practitioners in acute and critical care settings, this lecture provides a practical and systematic framework for applying pharmacology to hemodynamic instability. Gain a clearer understanding of how to target therapies, avoid common pitfalls, and optimize perfusion when it matters most.

Time is brain in emergency neurologic care. This session will review neurologic conditions and illnesses that commonly contribute to the development of neurologic emergencies. Case studies will be utilized to examine and apply treatment protocols and practice guidelines to patient care scenarios for this presentation.

This presentation will focus on evaluation, assessment, diagnosis, treatment and management of common inpatient Gastroenterology and Hepatology conditions. This will include updates in the management of acute pancreatitis, decompensated cirrhosis, acute liver failure, alcohol related hepatitis, Gastrointestinal bleeding (upper/lower), cholangitis/choledocholithiasis, inflammatory bowel disease (flare of ulcerative colitis and Crohns disease), dysphagia, diarrhea/colitis, constipation/impactions, and ileus

Heart failure (HF) prevalence and mortality continue to increase in the United States. Heart failure will affect 1 in 4 people during their lifetime. As we see patients in various settings, it is imperative to recognize that HF can present in unique ways, complicating diagnosis and management. Heart failure is no longer a straightforward diagnosis affecting a particular subset of aging patient. Being able to differentiate between heart failure and other disease processes is key to providing patients with the most appropriate treatment options. Early recognition of heart failure combined with a guideline-directed care can improve outcomes and quality of life for our patients. This presentation will equip you to recognize and manage typical and atypical heart failure presentations and enhance your ability to deliver comprehensive, evidence-based, patient-focused care that will improve outcomes for your patients with heart failure.

This session explores the updated KDIGO guidelines for acute kidney injury and chronic kidney disease in detail to enrich the learner's knowledge of this disease process and treatment. Complex pathophysiology, advanced diagnosis, etiologies, treatment modalities and long-term term considerations for patients with kidney injury are discussed. Safe-prescribing practices regarding certain nephrotoxic pharmacological agents and prevention and management of contrast induced nephropathy are discussed. Case studies are discussed to solidify discussion points.

This presentation focuses on the interplay of the heart and kidneys, how cardiorenal syndrome impacts heart failure management, and how progression of heart failure and chronic kidney disease impacts prognosis and management.

Echocardiography is one of the most widely used diagnostic tools in cardiology—but interpreting results and understanding its role among other cardiovascular diagnostics can be challenging for many nurse practitioners. This session offers a practical, case-based introduction to cardiovascular diagnostic testing with a focus on echocardiography. Participants will review key principles of test selection, gain a foundational understanding of echocardiogram modalities (TTE, TEE, stress echo), and learn to identify hallmark findings in common cardiovascular conditions. The session will also explore when to escalate care, collaborate with cardiology—including its subspecialties—and recognize limitations of testing. Designed for nurse practitioners who manage adult cardiovascular patients in inpatient or outpatient settings, this session emphasizes clinical relevance over technical detail. Attendees will leave with greater confidence in ordering, interpreting, and applying diagnostic testing to support timely, patient-centered decision-making.

This presentation provides an overview of pacemaker and ICD indications and how to apply device interrogation data to clinical practice. Novel and emerging device therapies to support dysrhythmia patients will also be discussed.

In this session, we will explore the intricate landscape of amyloidosis, focusing on common pitfalls during the diagnostic and management processes. Through case studies, the multifaceted nature of the most common types of cardiac amyloidosis (Light Chain and Transthyretin Amyloidosis) will be illustrated. Practical considerations will be explored including utilization of endomyocardial biopsy, specialty referrals, and symptom management for patients with amyloid heart disease.

During this dynamic presentation we will discuss unique risk factors, diagnoses and treatment considerations for providing cardiovascular care for vulnerable populations. We will discuss opportunities to address cardiovascular health disparities in caring for older adults, women, People of Color and LGBTQ+ persons and the influence of social drivers of health in these populations.

This session offers a practical overview of the different types of cardiomyopathies, focusing on their key differences on presentation, diagnosis and management. This will highlight clinical red flags, essential diagnostic tools and current, evidence based treatment strategies with emphasis on improving patient outcomes through early recognition and collaborative care.

"The rapid evolution of structural heart disease management—fueled by advancements in transcatheter therapies, sophisticated imaging, and multidisciplinary care—has significantly transformed the role of the Advanced Practice Provider (APP). What was once the exclusive realm of surgical intervention has expanded to include a wide spectrum of minimally invasive options, such as TAVR, TMVR, and the recent introduction of tricuspid therapies. These innovations are reshaping patient care, enhancing outcomes, and broadening access to treatment for high-risk populations—placing APPs at the forefront of procedural planning, care coordination, and longitudinal management within high-performing heart teams.
We’ll examine how the intersection of understanding valvular heart disease, cutting-edge technology, evidence-based protocols, and collaborative heart teams has elevated outcomes and access. Key challenges—such as optimal patient selection, procedural timing, and ensuring equitable implementation will be explored. This intersection of science, strategy, and teamwork is driving the next era of structural heart care."

Let's get back to the basics of skin with identifying common benign and malignant skin lesions. Learn how to assess skin lesions, what to do with these lesions, discuss biopsy techniques, and finally review pathology to know when it's ok to keep in your clinic and when to refer.

This 60-minute lecture provides an in-depth exploration of autoimmune diseases with dermatologic manifestations, focusing on conditions frequently encountered in clinical practice. The session will begin with a concise overview of the pathophysiology of autoimmune responses affecting the skin, followed by a focused discussion on key conditions such as lupus erythematosus, dermatomyositis, pemphigus vulgaris, bullous pemphigoid, and psoriasis with autoimmune overlap. Participants will learn to recognize hallmark clinical features, interpret relevant diagnostic tests, and navigate the evolving landscape of systemic and topical immunomodulatory therapies. Emphasis will be placed on evidence-based management strategies, patient-centered care, and practical tips for differentiating between similar-appearing conditions. By the end of the lecture, attendees will have strengthened their ability to identify autoimmune skin diseases early, initiate appropriate workups, and optimize treatment plans—enhancing outcomes for patients with complex dermatologic autoimmune disorders.

This presentation will review both new drugs and new FDA indications in the field of dermatology for 2024 and the first half of 2025. We will also highlight the updated 2024 AAD guidelines for both acne and atopic dermatitis. Lastly, if time permits, we will review a few recent pertinent articles affecting dermatology practice.

Learn about two of the most common women’s health dermatology conditions seen in the primary care clinic: hidradenitis suppurativa and lichen sclerosus. These conditions significantly affect the quality of life of afflicted female patients. Both can be time consuming to manage and difficult to treat. A clinical toolbox on how best to manage these conditions will be provided, as well as information on identifying key factors that would lead to a dermatology referral.

Feeling itchy just reading the title? This presentation dives deep into the wide array of infestations, bites, and stings that dermatology practitioners encounter. Led by Avery Dinallo, DNP, FNP-C, DCNP, this session will provide a comprehensive overview of conditions caused by creepy crawlers, biting critters, and aquatic encounters. From identifying scabies to managing fire ant bites, this presentation will equip you with the knowledge to diagnose and treat a variety of conditions effectively.

In this presentation, I will discuss the symptoms of facial aging, as well as non-surgical ways to prevent and treat these symptoms. I will discuss anti-aging skincare, collagen induction therapy, energy-based treatments, biostimulators, dermal fillers, and neuromodulators.

Discuss presentation and management of common pediatric rashes. From eczema to scabies to measles, come learn or refresh your knowledge of these classic and emerging pediatric dermatoses!

This session will review the use of Glucagon-Like Peptide 1 receptor agonists (GLP-1 ras) to manage patients at high risks for metabolic-cardiovascular-renal disease. The pharmacokinetics and mechanisms of action of the class of agents will be explored, emphasizing the mechanisms that are theorized to improve multiple patient outcomes. The GLP-1ra agents will be compared in terms of efficacy, weight loss, side effects and contraindications. Future application and indications of several agents will be included as well as pearls of practice to improve overall patient adherence.

This presentation will explore the pathophysiology, clinical manifestations, and management strategies of hyperparathyroidism. Attendees will gain insight into the "calcium chaos" caused by overactive parathyroid glands, learn how to order and interpret appropriate diagnostic tests and review current treatment options including surgical, medical, and monitoring approaches. Case studies will highlight common challenges and practical decision making in primary hyperparathyroidism.

As obesity is increasingly recognized as a chronic, progressive, and neurobehavioral disease, pharmacologic treatment has become a cornerstone of effective, long-term management. This presentation will provide a comprehensive review of current and emerging anti-obesity medications, focusing on mechanisms of action, indications, dosing strategies, contraindications, and adverse effect profiles. Participants will explore drug classes including sympathomimetic agents, GLP-1 receptor agonists, combination therapies, and newer agents such as dual and triple incretin receptor agonists. Clinical case studies will guide the application of pharmacologic principles in real-world scenarios, emphasizing individualized therapy based on comorbidities and patient preferences. The session will also address deprescribing obesogenic medications and optimizing polypharmacy in complex patients. Additionally, the presentation will highlight systemic challenges, including limited pharmacotherapy utilization and weight-related bias in prescribing patterns. Nurse practitioners will gain enhanced competency in selecting, initiating, titrating, and monitoring obesity medications in alignment with current clinical guidelines and evidence-based practice.

CGM technology has become a valuable tool in the management of diabetes to detect trends in glucose levels, identify asymtompatic glycemic excursions, and glycemic variability. A multitude of studies have demonstrated improved patient outcomes with continuous CGM use including improved A1C levels, reduced hypoglycemia, and increased patient satisfaction rates. To optimize this technology, it is important for NPs in primary care to have proficiency in all aspects off CGM use. This presentation will utilize case studies to demonstrate the key concepts of CGM use in primary care.

Updates on the clinical benefits of SGLT2-I in Diabetes Care and other guidelines directed therapy.

This presentation will focus on the most common challenges that NPs face in primary care with initiating and adjusting insulin therapy in Type 2 Diabetes management and solutions to address these challenges. A case study approach will be utilized to demonstrate practical applications in the clinical setting.

This presentation will review thyroid physiology and pathophysiology and discuss the diagnostic workup and management of emergent and urgent thyroid disorders. We will apply this knowledge through a case discussion focusing on pharmacologic management and disposition decision making.

This presentation will provide a clinical overview of the latest advances in the use of long-acting injectables for the treatment and prevention of HIV infection. Information on patient selection, monitoring, and follow-up will be reviewed. Challenges and strategies to overcome barriers to implementation in clinical practice will also be highlighted.

This presentation will detail the epidemiology, diagnosis, prevention and management of TB infection.

Pediatric myocarditis is a rare but potentially life-threatening condition that often presents with nonspecific symptoms, making early recognition a critical challenge for healthcare providers. This presentation will explore the pathophysiology, clinical presentation, diagnostic approach, and current management strategies for myocarditis in children. Through real-world case examples and the latest evidence-based guidelines, attendees will gain a deeper understanding of how to identify red flags, interpret key diagnostic findings, and initiate timely interventions to improve outcomes. Emphasis will be placed on distinguishing myocarditis from other common pediatric illnesses, recognizing the subtle early signs, and supporting families through diagnosis, treatment, and recovery. Whether you're in the emergency room, inpatient setting, or outpatient clinic, this session will equip you with the tools to act confidently when every second counts.

This presentation examines the most current epidemiologic and treatment data on two of the most common categories of infection seen in long-term care settings. The first portion of this exposition will focus on respiratory tract infections, specifically on the differential diagnosis and treatment of sinusitis, bronchitis, and pneumonias. Topics covered will include focused history and physical examination of the respiratory system, essential diagnostic testing to differentiate between these common pulmonary infections, and pharmacologic management. Optimal treatment modalities between these three morbidities will be compared. The second portion will concentrate on urinary tract infections (UTIs), specifically on the differential diagnosis and treatment of uncomplicated and complicated UTIs. Topics covered will include focused history of the urinary system, essential diagnostic testing to differentiate between complicated and uncomplicated UTIs, and pharmacologic management. Treatment modalities between uncomplicated and complicated UTIs will be compared. The presentation will also highlight respiratory and urinary tract infection prevention strategies nurse practitioner clinicians can employ to improve health outcomes for vulnerable populations requiring long-term care.

This presentation will review the epidemiology, natural history, clinical presentation, diagnosis, prevention and treatment of syphilis.

Viral hepatitis is a main driver of chronic liver disease, liver cancer and liver failure worldwide. This presentation will review the differences between viral hepatitis A, B, C and D including transmission, prevention tactics, diagnosis, clinical management and treatment options. The epidemiology and natural history of each form of viral hepatitis induced liver disease will be discussed. A relevant case study to highlight the key features of diagnosis and management of viral hepatitis infections will be included.

This presentation aims to provide clinical updates in infectious disease care of solid organ transplant patients. We will review pre-transplant evaluation protocols, peri-transplant infectious disease considerations and post transplant prevention, screening and treatment. We will discuss novel organ sources including donors with Hepatitis C and/or HIV and the changes to national law making these transplant standard of practice. Finally, we will review research to date on the transplantation of organs from genetically modified pigs.

This presentation will review current epidemiology, diagnostic criteria, and pathophysiology of migraine. A focus on standard of care therapy and new treatment, including neuromodulatory devices, onabotulinum toxin A, and CGRP antagonists, will be presented. Selection of appropriate agents, both acute and preventative, will be discussed. Clinical signs associated with intracranial pathology will be reviewed.

This presentation gives a review of the origins of auricular therapy and the possible mechanisms of action. Further detail includes: the medical diagnoses that can be treated with auricular therapy, several of the most common protocols, current research supporting the use of this treatment modality, precautions and information on the cost of auricular therapy. This presentation includes several case presentations which helps in understanding the ease and importance of utilizing this valuable skill in the treatment of multiple health issues.

Epilepsy is the fourth most commonly diagnosed neurology condition effecting 3.4 million people in the United States. Advance practice providers (APPs) play a crucial role in caring for patients with epilepsy and are often the first healthcare provider involved in related evaluations. This is increasingly relevant due to decreased access to specialty clinics and a decline in physicians entering the field of neurology. Educating advanced practice providers on epilepsy essentials is crucial for enhancing clinical practice directly affecting patient outcomes. This presentation will focus on the most commonly asked clinical queries associated with epilepsy. The discussion will specifically address functional seizures, single seizures, driving, pregnancy, co-morbidities, seizure action plans and antiseizure medication weaning. Attendees will gain an increased understanding of customized approaches to improved patient outcomes, as well as identify and address gaps in care. The discussion will provide precise, evidence-based education, and best practices associated with diagnostic approaches, treatment and clinical pearls for evaluating and managing patients with epilepsy.

Nociplastic pain is a type of chronic pain that arises from altered pain processing in the central nervous system (CNS), rather than from tissue damage or nerve injury. It's characterized by pain that is more widespread or intense than expected given the degree of tissue or nerve damage, and is often accompanied by symptoms like fatigue, sleep disturbances, and cognitive dysfunction.

This lecture will provide the audience with an overview of this new pain classification and tools to diagnosis and manage these challenging pain conditions.

Parkinson’s disease (PD) is a chronic, progressive disorder that requires interdisciplinary care to allow the PD patient to live their best life. Caring for these patients is highly rewarding. This presentation will provide an overview and update on the management of PD. PD features, diagnostic criteria, the movement disorder examination, disease progression, medication management, surgical therapies including Deep Brain Stimulation, and interdisciplinary care throughout the continuum of disease will be examined. Hospitalization considerations, support for the caregiver and palliative care will be discussed.

DEI along with accessibility and health disparities have been gaining marked attention in health care. One relevant group is that of neurodiversity. Neurodiversity is used to describe diversity and variance in brain function and cognition due to lifelong conditions that affect normative intellectual development and function. This includes intellectual and other developmental disabilities, such as autism spectrum disorder, cerebral palsy, acquired or traumatic brain injury before the age of 22 and lifelong sensory impairments. They are aging despite health and social disparities which includes being able to access quality informed services. Frankly these individuals can be the most confounding to medically support as they age. The assessment of dementia is falling more to primary care providers. This intersection of neurodiversity and dementia can be daunting.  Using the lens of new Alzheimer’s Association’s clinical guidelines (DETeCD-ADRD), this presentation will outline evidence-informed and practical considerations for the neurodiverse population. Although there is scant research, years of clinical practice will guide the conversations so that the audience will be able to organize their encounters from first suspicion constructing a meaningful base to structure and guide the continuum. Diagnostic overshadowing and differential diagnoses will be highlighted particularly as germane to the population.

This presentation will provide an overview of the management of opioid use disorder using a harm-reductionistic and radically empathetic approach. Identification of opioid use disorder will be discussed, including diagnostic criteria for opioid use disorder and opioid withdrawal. Non-pharmacological interventions, including motivational interviewing, will be reviewed, with an additional focus on medications for opioid use disorder (MOUD), including methadone, buprenorphine, and naltrexone.

This presentation explores recent developments in the assessment, diagnosis, and treatment of eating disorders, including anorexia nervosa, bulimia nervosa, and binge-eating disorder. Emphasis will be placed on the role of environmental, psychological, and sociocultural factors. The session will highlight current best practices in evidence-based interventions, to include evidence-based therapy modalities and pharmacological approaches. Special attention will be given to challenges in treatment engagement, the impact of comorbid psychiatric conditions, and strategies for supporting recovery and long-term maintenance. Attendees will gain practical insights for clinical practice and a deeper understanding of the complexities surrounding eating disorders across diverse populations.

Self-harm among children and adolescents is increasing at an alarming rate, yet it often remains hidden behind silence, shame, and misunderstanding. This presentation explores the complex phenomenon of non-suicidal self-injury (NSSI), offering a clinically grounded, research-informed approach to understanding why young people engage in these behaviors. Participants will gain insights into the emotional, psychological, and social drivers of NSSI and how these differ from suicidal intent. Through case examples and evidence-based guidance, this session will empower nurse practitioners to recognize frequently overlooked signs, ask questions confidently, and intervene with sensitivity and effectiveness. Whether practicing in primary care or mental health settings, clinicians must be equipped to address NSSI with timeliness, clinical clarity, and compassion. This is a vital opportunity to build competence in an area that demands professional expertise and human connection.

This presentation will enable to the learner to assess, diagnose and manage delirium in the adult/geriatric patient. Various methods of assessment will be discussed, as well as the myriad causes of delirium and the neuropsychiatric effects on the brain. We will explore the many pharmacologic and non-pharmacologic treatments used to alleviate delirium.

Personality Disorders in Everyday Practice: Assessment and Management Strategies for Nurse Practitioners" equips nurse practitioners across specialties with practical approaches for managing patients with personality disorder traits in diverse healthcare settings. This presentation bridges psychiatric expertise with everyday clinical practice, addressing how these disorders influence treatment adherence, healthcare utilization, and provider-patient relationships. Attendees will learn to recognize key personality disorder presentations commonly encountered in non-psychiatric settings, focusing on features that directly impact clinical care. Through realistic case scenarios from primary care, specialty practice, and acute care environments, participants will explore evidence-based communication strategies that enhance therapeutic engagement while preserving professional boundaries. The session provides a straightforward collaborative care framework that balances medical interventions with psychological approaches, emphasizing when and how to coordinate with mental health specialists. Grounded in both psychiatric nursing and counseling perspectives, this presentation offers immediately applicable tools to improve clinical interactions and patient outcomes. Participants will gain confidence in managing challenging patient encounters and develop specific interventions to enhance care for patients with personality disorders, regardless of practice specialty.

Insomnia is highly common, with nearly a third of Americans experiencing sleep difficulties. The goal of this presentation is to provide holistic and evidenced-based recommendations for addressing this widespread issue.

This presentation will dive into the recent Sepsis Guidelines with a special focus on the pharmacology involved in treating critically ill patients with sepsis.

Exploring evidence-based, non-pharmacologic strategies that complement or, in some cases, replace traditional medication-based approaches in the management of both acute and chronic conditions. From lifestyle interventions and behavioral therapies to integrative modalities and care coordination, we’ll examine practical tools clinicians can use to optimize patient outcomes. Special emphasis will be placed on strategies for conditions commonly seen in primary and emergency care, such as chronic pain, hypertension, anxiety, and migraine. Attendees will leave with actionable techniques to incorporate into practice and improve whole-person care.

This session will explore the historical development, current landscape, and future directions of anticoagulants. Nurse Practitioners will gain an understanding of the clotting cascade, patient-specific safety considerations, and evidence-based prescribing practices. Through case-based learning and clinical pearls, participants will be prepared to manage anticoagulation across diverse clinical settings.

GLP-1 receptor agonists are transforming the management of conditions such as type 2 diabetes and obesity. This presentation offers an in-depth review of their mechanisms, evolution, indications, and safety concerns. Using a case-based approach, this session will highlight best practices and potential future directions in GLP-1 therapy.

This presentation will highlight some of the key updates in endocrine pharmacology in 2025 in important areas such as testosterone management, insulin/anti-hyperglycemics, weight management, and continuous glucose monitoring.

Emergency and acute care nurse practitioners frequently encounter patients with various toxic exposures and ingestions, whether accidental or intentional. Managing these cases often requires navigating complex and evolving treatment strategies. This presentation will cover common toxidromes, a broad spectrum of toxins, medications, and substances, as well as emerging drugs of abuse such as xylazine. Additionally, innovative treatment approaches, including high-dose insulin therapy and intralipid administration, will be explored. By the end of this session, participants will gain updated knowledge and practical strategies to enhance their management of toxicological emergencies.

This session provides nurse practitioners with a comprehensive overview of evidence-based pharmacological interventions for managing Alzheimer's disease and related dementias. The presentation will primarily focus on established treatment modalities for cognitive symptoms and functional decline. Attendees will learn practical approaches to managing common neuropsychiatric symptoms of dementia, from anxiety and depression to disordered sleep, agitation, and psychosis, with special consideration of risk-benefit analyses for various medication classes. The session will address important considerations for geriatric pharmacology. We will also discuss appropriate use of emerging therapies in the Alzheimer's treatment landscape, including disease-modifying treatments. Participants will gain practical knowledge to optimize referrals to subspecialist care and treatment, along with guidance for medication management for patients with dementia, focusing on appropriate drug selection, symptom target identification, and monitoring for therapeutic outcomes and adverse effects.